Global Fingerprint Sensor Market Research Report—Forecast till 2026

Table of Contents

TABLE OF CONTENT 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 16 2.2 RESEARCH OBJECTIVE 16 2.3 LIST OF ASSUMPTIONS & LIMITATIONS 17 3 RESEARCH METHODOLOGY 3.1 OVERVIEW 19 3.2 DATA MINING 19 3.3 SECONDARY RESEARCH 20 3.4 PRIMARY RESEARCH 21 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 21 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 22 3.5 FORECASTING TECHNIQUES 23 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24 3.6.1 BOTTOM-UP APPROACH 24 3.6.2 TOP-DOWN APPROACH 25 3.7 DATA TRIANGULATION 26 3.8 VALIDATION 26 4 MARKET DYNAMICS 4.1 OVERVIEW 27 4.2 DRIVERS 28 4.2.1 IMPROVEMENT IN SURGICAL OUTCOMES 28 4.2.2 INCREASING PREVALENCE OF CHRONIC DISEASES 28 4.2.3 GROWING GERIATRIC POPULATION 29 4.3 RESTRAINTS 30 4.3.1 AMBIGUOUS REGULATORY FRAMEWORK 30 4.3.2 RISK OF INFECTIONS DUE TO MEDICAL IMPLANTS 30 4.4 OPPORTUNITY 31 4.4.1 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL IMPLANTS 31 5 MARKET FACTOR ANALYSIS 5.1 SUPPLY CHAIN ANALYSIS 33 5.1.1 R&D AND DESIGNING 34 5.1.2 MANUFACTURING 34 5.1.3 DISTRIBUTION 34 5.1.4 MARKETING & SALES 34 5.2 PORTER’S FIVE FORCES MODEL 35 5.2.1 THREAT OF NEW ENTRANTS 36 5.2.2 BARGAINING POWER OF SUPPLIERS 36 5.2.3 THREAT OF SUBSTITUTES 36 5.2.4 BARGAINING POWER OF BUYERS 36 5.2.5 INTENSITY OF RIVALRY 36 5.3 IMPACT OF COVID-19 37 5.3.1 IMPACT ON DEMAND 37 5.3.2 IMPACT ON SUPPLY 37 5.3.3 IMPACT ON MARKET PLAYER 37 6 GLOBAL MEDICAL IMPLANTS MARKET, BY TYPE 6.1 OVERVIEW 38 6.2 ORTHOPEDIC IMPLANTS 39 6.3 CARDIAC IMPLANTS 40 6.4 SPINAL IMPLANTS 41 6.5 DENTAL IMPLANTS 42 6.6 OPHTHALMIC IMPLANTS 43 6.7 COSMETIC IMPLANTS 44 6.8 OTHERS 45 7 GLOBAL MEDICAL IMPLANTS MARKET, BY TYPE OF MATERIAL 7.1 OVERVIEW 46 7.2 METALLIC MATERIAL 47 7.3 CERAMIC MATERIAL 47 7.4 POLYMERS MATERIAL 48 7.5 OTHERS 49 8 GLOBAL MEDICAL IMPLANTSMARKET, BY END USER 8.1 OVERVIEW 50 8.2 HOSPITALS & CLINICS 51 8.3 SPECIALTY CENTRES 51 8.4 OTHERS 52 9 GLOBAL MEDICAL IMPLANTS MARKET, BY REGION 9.1 OVERVIEW 53 9.2 AMERICAS 54 9.2.1 NORTH AMERICA 57 9.2.1.1 US 60 9.2.1.2 CANADA 62 9.2.2 LATIN AMERICA 64 9.3 EUROPE 67 9.3.1 WESTERN EUROPE 70 9.3.1.1 GERMANY 73 9.3.1.2 FRANCE 75 9.3.1.3 UK 77 9.3.1.4 ITALY 79 9.3.1.5 SPAIN 81 9.3.1.6 REST OF WESTERN OF EUROPE 83 9.3.2 EASTERN EUROPE 85 9.4 ASIA-PACIFIC 88 9.4.1 JAPAN 91 9.4.2 CHINA 93 9.4.3 INDIA 95 9.4.4 AUSTRALIA 97 9.4.5 SOUTH KOREA 99 9.4.6 REST OF ASIA-PACIFIC 101 9.5 MIDDLE EAST & AFRICA 104 9.5.1 MIDDLE EAST 107 9.5.2 AFRICA 109 10 COMPETITIVE LANDSCAPE 10.1 OVERVIEW 112 10.2 GLOBAL MEDICAL IMPLANTS MARKET SHARE ANALYSIS (2019) 112 10.3 COMPETITIVE BENCHMARKING 113 10.4 MAJOR GROWTH STRATEGIES IN THE GLOBAL MEDICAL IMPLANTS MARKET 114 10.5 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MEDICAL IMPLANTS MARKET 114 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 115 10.6.1 EXPANSION 115 10.6.2 PRODUCT APPROVAL/FDA APPROVAL 116 11 COMPANY PROFILES 11.1 BOSTON SCIENTIFIC CORPORATION 117 11.1.1 COMPANY OVERVIEW 117 11.1.2 FINANCIAL OVERVIEW 117 11.1.3 PRODUCTS/SERVICES OFFERED 118 11.1.4 KEY DEVELOPMENTS 119 11.1.5 SWOT ANALYSIS 120 11.1.6 KEY STRATEGIES 120 11.2 MEDTRONIC PLC 121 11.2.1 COMPANY OVERVIEW 121 11.2.2 FINANCIAL OVERVIEW 121 11.2.3 PRODUCTS/SERVICES OFFERED 122 11.2.4 KEY DEVELOPMENTS 124 11.2.5 SWOT ANALYSIS 125 11.2.6 KEY STRATEGIES 125 11.3 JOHNSON & JOHNSON SERVICES, INC. 126 11.3.1 COMPANY OVERVIEW 126 11.3.2 FINANCIAL OVERVIEW 126 11.3.3 PRODUCTS/SERVICES OFFERED 127 11.3.4 KEY DEVELOPMENTS 127 11.3.5 SWOT ANALYSIS 128 11.3.6 KEY STRATEGIES 128 11.4 3M 129 11.4.1 COMPANY OVERVIEW 129 11.4.2 FINANCIAL OVERVIEW 129 11.4.3 PRODUCTS/SERVICES OFFERED 130 11.4.4 KEY DEVELOPMENTS 130 11.4.5 SWOT ANALYSIS 131 11.4.6 KEY STRATEGIES 131 11.5 INSTITUT STRAUMANN AG 132 11.5.1 COMPANY OVERVIEW 132 11.5.2 FINANCIAL OVERVIEW 132 11.5.3 PRODUCTS/SERVICES OFFERED 133 11.5.4 KEY DEVELOPMENTS 134 11.5.5 SWOT ANALYSIS 135 11.5.6 KEY STRATEGIES 135 11.6 STRYKER 136 11.6.1 COMPANY OVERVIEW 136 11.6.2 FINANCIAL OVERVIEW 136 11.6.3 PRODUCTS/SERVICES OFFERED 137 11.6.4 KEY DEVELOPMENTS 137 11.6.5 SWOT ANALYSIS 138 11.6.6 KEY STRATEGIES 138 11.7 ZIMMER BIOMET HOLDINGS INC. 139 11.7.1 COMPANY OVERVIEWS 139 11.7.2 FINANCIAL OVERVIEW 139 11.7.3 PRODUCTS/SERVICES OFFERED 140 11.7.4 KEY DEVELOPMENTS 140 11.7.5 SWOT ANALYSIS 141 11.7.6 KEY STRATEGIES 141 11.8 SMITH & NEPHEW 142 11.8.1 COMPANY OVERVIEW 142 11.8.2 FINANCIAL OVERVIEW 142 11.8.3 PRODUCTS/SERVICES OFFERED 143 11.8.4 KEY DEVELOPMENTS 143 11.8.5 SWOT ANALYSIS 144 11.8.6 KEY STRATEGIES 144 11.9 DENTSPLY SIRONA 145 11.9.1 COMPANY OVERVIEW 145 11.9.2 FINANCIAL OVERVIEW 145 11.9.3 PRODUCTS/SERVICES OFFERED 146 11.9.4 KEY DEVELOPMENTS 146 11.9.5 SWOT ANALYSIS 147 11.9.6 KEY STRATEGIES 147 11.10 B. BRAUN MELSUNGEN AG 148 11.10.1 COMPANY OVERVIEW 148 11.10.2 FINANCIAL OVERVIEW 148 11.10.3 PRODUCTS/SERVICES OFFERED 149 11.10.4 KEY DEVELOPMENTS 149 11.10.5 SWOT ANALYSIS 150 11.10.6 KEY STRATEGIES 150 12 APPENDIX 12.1 REFERENCES 151 12.2 RELATED REPORTS 151